CANF Stock-Based Compensation
Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · Stock-Based Compensation
CANF Stock-Based Compensation
Latest reported$181.00Kperiod ending
CANF TTM Stock-Based Comp ($83.04K → $181.00K)
TTM stock-based compensation
High-resolution chart · PNG
CANF stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 181,000 | |
| 260,500 | |
| 340,000 | |
| 380,000 | |
| 420,000 | |
| 391,000 | |
| 362,000 | |
| 538,500 | |
| 359,000 | |
| 357,500 | |
| 261,000 | |
| 263,000 | |
| 223,000 | |
| 263,000 | |
| 263,000 | |
| 466,000 | |
| 367,000 | |
| 466,000 | |
| 466,000 | |
| 355,000 | |
| 490,000 | |
| 355,000 | |
| 355,000 | |
| 385,000 | |
| 333,000 | |
| 385,000 | |
| 385,000 | |
| 535,000 | |
| 262,000 | |
| 535,000 | |
| 535,000 | |
| 192,000 | |
| 521,807 | |
| 192,807 | |
| 192,807 | |
| 309,807 | |
| 214,878 | |
| 254,922 | |
| 254,922 | |
| 59,357 | |
| 216,090 | |
| 114,699 | |
| 114,699 | |
| 213,259 | |
| 165,557 | |
| 217,922 | |
| 217,922 | |
| 126,544 | |
| 388,810 | |
| 733,160 | |
| 777,225 | |
| 735,344 | |
| 633,645 | |
| 350,729 | |
| 395,765 | |
| 341,561 | |
| 262,832 | |
| 138,452 | |
| 83,045 | |
| 204,367 |